Lombard Odier Asset Management (USA)’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,448
| Closed | -$554K | – | 265 |
|
|
2024
Q1 | $554K | Buy |
+14,448
| New | +$554K | 0.01% | 119 |
|
|
2023
Q4 | – | Sell |
-8,504
| Closed | -$637K | – | 269 |
|
|
2023
Q3 | $637K | Buy |
8,504
+949
| +13% | +$71.1K | 0.01% | 96 |
|
|
2023
Q2 | $696K | Buy |
7,555
+3,772
| +100% | +$348K | 0.01% | 102 |
|
|
2023
Q1 | $392K | Buy |
+3,783
| New | +$392K | 0.01% | 104 |
|
|
2022
Q4 | – | Sell |
-3,678
| Closed | -$399K | – | 252 |
|
|
2022
Q3 | $399K | Buy |
+3,678
| New | +$399K | 0.01% | 147 |
|
|
2021
Q2 | – | Sell |
-22,650
| Closed | -$4.8M | – | 265 |
|
|
2021
Q1 | $4.8M | Buy |
+22,650
| New | +$4.8M | 0.18% | 26 |
|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$6.58M | – | 185 |
|
|
2020
Q3 | $6.58M | Sell |
40,000
-53,705
| -57% | -$8.83M | 0.43% | 27 |
|
|
2020
Q2 | $13M | Buy |
93,705
+78,470
| +515% | +$10.9M | 0.91% | 7 |
|
|
2020
Q1 | $952K | Sell |
15,235
-161,402
| -91% | -$10.1M | 0.1% | 112 |
|
|
2019
Q4 | $19.4M | Buy |
+176,637
| New | +$19.4M | 1.73% | 6 |
|
|
2019
Q3 | – | Sell |
-87,266
| Closed | -$11.2M | – | 225 |
|
|
2019
Q2 | $11.2M | Buy |
87,266
+15,798
| +22% | +$2.03M | 0.9% | 27 |
|
|
2019
Q1 | $9.12M | Buy |
+71,468
| New | +$9.12M | 0.75% | 27 |
|
|
2018
Q4 | – | Sell |
-12,000
| Closed | -$2.66M | – | 204 |
|
|
2018
Q3 | $2.66M | Buy |
+12,000
| New | +$2.66M | 0.2% | 93 |
|